Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$0.25 - $9.02 $2,836 - $102,322
11,344 Added 5.48%
218,442 $54,000
Q2 2022

Aug 12, 2022

BUY
$0.55 - $1.19 $5,438 - $11,767
9,889 Added 5.01%
207,098 $127,000
Q4 2021

Feb 11, 2022

SELL
$1.0 - $2.0 $3,543 - $7,086
-3,543 Reduced 1.76%
197,209 $205,000
Q3 2021

Nov 12, 2021

BUY
$0.7 - $3.37 $44,707 - $215,235
63,868 Added 46.66%
200,752 $413,000
Q2 2021

Aug 13, 2021

BUY
$0.79 - $1.15 $29,625 - $43,126
37,501 Added 37.73%
136,884 $116,000
Q1 2021

May 12, 2021

BUY
$0.83 - $1.51 $61,176 - $111,297
73,707 Added 287.07%
99,383 $100,000
Q4 2020

Feb 12, 2021

BUY
$0.56 - $1.13 $14,378 - $29,013
25,676 New
25,676 $19,000

Others Institutions Holding NAOV

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About NanoVibronix, Inc.


  • Ticker NAOV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,997,800
  • Market Cap $16.2M
  • Description
  • NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary ca...
More about NAOV
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.